Brief: Autolus Announces Proposed Public Offering In The United States
08/12/2022 21:28
Dec 8 (Reuters) - Autolus Therapeutics PLC AUTL.O :
* AUTOLUS ANNOUNCES PROPOSED PUBLIC OFFERING IN THE UNITED
STATES
* AUTOLUS THERAPEUTICS PLC - HAS COMMENCED UNDERWRITTEN
PUBLIC
OFFERING OF ADSS, EACH ADS REPRESENTING ONE ORDINARY SHARE
Source text for Eikon: ID:nGNX36BCSM
Further company coverage: AUTL.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Autolus Therapeutics
See all newsBrief: Autolus Therapeutics PLC Unit Enters Master Service Agreement With AGC Biologics
Brief: Autolus Therapeutics Appoints Ryan Richardson To Board Of Directors
Brief: Nice Recommends Aucatzyl As A Treatment Option For Adult Patients With Lymphoblastic Leukemia
Brief: Autolus Therapeutics’ Car T Therapy Aucatzyl® (Obecabtagene Autoleucel) Granted European Marketing Authorization For Adult Patients
Brief: Autolus Therapeutics Announces Inducement Grants